Bioptical differential diagnosis of adenomas, dysplesias and carcinomas in patients with ulcerative colitis;Bioptische differenzialdiagnostik von adenomen, dysplasien und karzinomen bei patienten mit colitis ulcerosa

Leber Magen Darm

Volumn 30, Issue 3, 2000, Pages 125-132

  Vieth, M ^a   Stolte, M ^a   Mueller, E ^b   Mueller, J ^b   Schneider, A ^c  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Institut für Pathologie Diakoniekrankenhaus Rotenburg W   (Germany)

Author keywords

Adenoma; Carcinoma; Dysplasia; Neoplasia; Ulcerative colitis

Indexed keywords

ADENOMA; ADULT; AGED; COLON CANCER; CYTOMETRY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NOTE; ULCERATIVE COLITIS;

EID: 0034104858     PISSN: 03008622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC. Dysplasie in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-968.
2. von Herbay A, Herfarth Ch, Otto HF. Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol 1994; 32: 382-388.
3. Nagasako K, Iizuka B, Ishii F, Miyazaki J, Fujimori T. Colonoscopic diagnosis of dysplasia and early cancer in longstanding colitis. J Gastroenterol. 1995; 30 Suppl 8: 36-39.
4. Melville DM, Jass JR, Shepherd NA, Northover JM, Capellaro D, Richman PI, Lennard-Jones JE, Ritchie JK, Andersen SN. Dysplasia and desoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlation. Gastroenterology 1988; 95: 668-675.
5. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8: 423-434.
6. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: Assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977; 73: 1280-1289.
7. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991; 100: 1241-1248.
8. Nugent FW, Haggitt RC, Colcher H, Kutteruf GC. Malignant potential of chronic ulcerative colitis: Preliminary report Gastroenterology 1979; 76: 1-5.
9. Connell WR, Lennard-Jones JE, Williams CB. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-944.
10. Fuson JA, Famer RG, Hawk A, Sullivan BH. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980; 73: 120-126.
11. Leidenius M, Kellokumpu I, Husa A, Riihela M, Sipponen P. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991; 32: 71-74.
12. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colits? Lancet 1994; 343: 71-74.
13. Clements D, Suarez V, Thompson H, Alexander-Williams J, Allan RN. Early onset high grade dysplasia in ulcerative colitis. Postgrad Med J 1988; 64: 77-78.
14. Schneider A, Stolte M. Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis. Z Gastroenterol 1993; 31: 192-197.
15. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer problems in assessing diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985; 28: 383-388.
16. Jass JR, Sobin LH. Histological typing of intestinal tumors. In: World Health Organisation, International histologica/classification of tumors. Berlin - Heidelberg - New York: Springer, 2nd ed, 1989, 2-3.
17. Borchard F, Heilmann KL, Hermanek P, Gebbers JO, Heitz PU, Stolte M, Pfeifer U, Schaefer HE, Wiebecke B, Schlake W. Definition und klinische Bedeutung der Dysplasie im Verdauungstrakt Pathologe 1991; 12: 50-56.
18. Riddell RH. Dysplasia in ulcerative colitis. In: Sherlock P, Morson BC, Barbara L et al. (eds). Precancerous lesions of the gastrointestinal tract; New York, Raven Press, 1983: 273-279.
19. Hermanek P. Dysplasia in the gastrointestinal tract: definition and clinical significance. Surg Endosc 1987; 1: 5-10.
20. Ishikawa M, Mibu R, Nakamura K, Sakai M, Oohata Y, Tanaka M. Correlation between macroscopic morphologic features and malignant potential of colorectal sessile adenomas. Dis Colon Rectum 1996; 39: 1275-1281
21. Porschen J, Strohmeyer G. Kolorektales Karzinomrisiko bei Colitis-ulcerosa - Überwachungsstrategien und Identifikation von Risikopatienten. Z Gastroenterol 1992; 30: 585-593.
22. Herfarth Ch, Otto HF. Carcinom-präventive Operationsindikationen bei entzündlichen Darmerkrankungen. Chirurg 1987; 58: 221-227.
23. Herfarth Ch, Stern J. Colitis ulcerosa - Adenomatosis coli. Funktionserhaltende Therapie. Berlin - Heidelberg - New York: Springer, 1980.
24. Schneider A, Stolte M. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol. 1993; 31: 653-656.
25. Schneider A, Stolte M. Colitis ulcerosa: Differentialdiagnose zwischen Dysplasie und Adenom. Verh Dtsch Ges Path 1991; 75: 389.
26. Mueller E, Vieth M, Stolte M, Mueller J. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol 1999; 30:898-905.
27. Clark JC, Collan Y, Eide TJ, Esteve J, Ewen S, Gibbs NM, Jensen OM, Koskela E, MacLennan R, Simpson JG. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 1985; 36: 179-186.
28. Geul KW, Bosman FT, van Blankenstein M, Grobbee DE, Wilson JH. Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol Suppl 1997; 223: 79-87.
29. Gatteschi B, Constantini M, Bruzzi P, Merlo F, Torcoli R, Nicolo G. Univariate and multivariate analyses of the relationship between adenocarcinoma and solitary and multiple adenomas in colorectal adenoma patients. Int J Cancer. 1991; 49: 509-512.
30. Shida H, Yamamoto T, Hiraiwa M, Kuroda T, Masuda K, Ishimaru J, Matsumura K, Imanari T, Machida T, Takahashi K. Colorectal cancer and synchronous adenomatous or malignant polyps - factors influencing its incidence. Gan No Rinsho. 1987; 33: 929-935.
31. Fogt F, Vortmeyer AO, Stolte M, Mueller E, Mueller J, Noffsinger A, Poremba C, Zhuang Z. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas. Hum Pathol 1998; 29: 961-964.
32. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288-1294.
33. Rubin PH, Friedman S, Harpaz N, Goldstein E, Weiser J, Schiller J, Waye JD, Present DH. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.